These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26987034)

  • 1. Lamotrigine monotherapy for paroxysmal kinesigenic dyskinesia in children.
    Li F; Lin ZD; Hu Y; Li W; Xue CC; Poonit ND
    Seizure; 2016 Apr; 37():41-4. PubMed ID: 26987034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine monotherapy for newly diagnosed typical absence seizures in children: A multi-center, uncontrolled, open-label study.
    Yasumoto S; Shimizu M; Sato K; Kurata A; Numachi Y
    Brain Dev; 2016 Apr; 38(4):407-13. PubMed ID: 26518979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine monotherapy for newly diagnosed typical absence seizures in children.
    Holmes GL; Frank LM; Sheth RD; Philbrook B; Wooten JD; Vuong A; Kerls S; Hammer AE; Messenheimer J
    Epilepsy Res; 2008 Dec; 82(2-3):124-32. PubMed ID: 18778916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
    Frank LM; Enlow T; Holmes GL; Manasco P; Concannon S; Chen C; Womble G; Casale EJ
    Epilepsia; 1999 Jul; 40(7):973-9. PubMed ID: 10403222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lamotrigine (LTG) monotherapy.
    Panayiotopoulos CP
    Epilepsia; 2000 Mar; 41(3):357-9. PubMed ID: 10714412
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study.
    Coppola G; Licciardi F; Sciscio N; Russo F; Carotenuto M; Pascotto A
    Brain Dev; 2004 Jan; 26(1):26-9. PubMed ID: 14729411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of lamotrigine monotherapy in Japanese and South Korean pediatric patients with newly diagnosed typical absence seizures: An open-label extension study.
    Yasumoto S; Ohtsuka Y; Sato K; Kurata A; Numachi Y; Shimizu M
    Brain Dev; 2018 Oct; 40(9):786-791. PubMed ID: 29861154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine.
    Pan G; Zhang L; Zhou S
    BMC Pediatr; 2019 Nov; 19(1):439. PubMed ID: 31722684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide for children with paroxysmal kinesigenic dyskinesia.
    Furukawa G; Negishi Y; Takeuchi T; Ishihara N; Okumura A
    Brain Dev; 2020 Sep; 42(8):617-620. PubMed ID: 32430160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H; Kim H; Kim SH; Kim SH; Lim BC; Chae JH; Choi JE; Kim KJ; Hwang YS
    Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
    Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA
    Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide Therapy for Patients With Paroxysmal Kinesigenic Dyskinesia.
    Matsuura R; Hamano SI; Hiwatari E; Ikemoto S; Hirata Y; Koichihara R; Kikuchi K
    Pediatr Neurol; 2020 Oct; 111():23-26. PubMed ID: 32951651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Capparelli EV; Adamson PC;
    N Engl J Med; 2010 Mar; 362(9):790-9. PubMed ID: 20200383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proline-rich transmembrane protein 2-negative paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 163 patients.
    Tian WT; Huang XJ; Mao X; Liu Q; Liu XL; Zeng S; Guo XN; Shen JY; Xu YQ; Tang HD; Yin XM; Zhang M; Tang WG; Liu XR; Tang BS; Chen SD; Cao L
    Mov Disord; 2018 Mar; 33(3):459-467. PubMed ID: 29356177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal Kinesigenic Dyskinesia.
    Paucar M; Malmgren H; Svenningsson P
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():529. PubMed ID: 29276650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.